Page 109 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 109
THE RELATION BETWEEN CARDIAC CONDUCTION TIMES
REFERENCES
1. Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 2015;11:693-704.
2. Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 2011;13:R131.
3. John H, Kitas G, Toms T, Goodson N. Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009;23:71-82.
4. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 2014;13:936-944.
5. Holmqvist ME, Wedren S, Jacobsson LT, Klareskog L, Nyberg F, Rantapaa-Dahlqvist S et
al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis
amongst patients diagnosed between 1995 and 2006. J Intern Med 2010;268:578-585. 5
6. Kerola AM, Kauppi MJ, Kerola T, Nieminen TV. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear? Ann Rheum Dis 2012;71:1606-1615.
7. Kerola AM, Kerola T, Kauppi MJ, Kautiainen H, Virta LJ, Puolakka K et al. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Ann Rheum Dis
2013;72:1826-1829.
8. Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S et al. Association
between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med 2013;24:368- 374.
9. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1286-1298.
10. MyasoedovaE,CrowsonCS,KremersHM,RogerVL,Fitz-GibbonPD,TherneauTMetal. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011;70:482-487.
11. Seferovic PM, Ristic AD, Maksimovic R, Simeunovic DS, Ristic GG, Radovanovic G et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006;45 Suppl 4:iv39-iv42.
12. ChauhanK,AckermanMJ,CrowsonCS,MattesonEL,GabrielSE.Population-basedstudy of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol 2015;33:84-89.
13. Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 2014;53:131-137.
14. Bemelmans RH, Visseren FL. [The resting heart rate]. Ned Tijdschr Geneeskd 2014;158:A6931.
107
